» Authors » Neil McDougall

Neil McDougall

Explore the profile of Neil McDougall including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 143
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fu M, Elsharkawy A, Healy B, Jackson C, Bradshaw D, Watkins E, et al.
EClinicalMedicine . 2025 Feb; 81:103095. PMID: 39975699
The implementation of effective blood donation screening for hepatitis B virus (HBV) anti-core antibodies with highly sensitive molecular HBV DNA detection in low-endemic countries like the United Kingdom has improved...
2.
Tavabie O, Kronsten V, Przemioslo R, McDougall N, Ramos K, Joshi D, et al.
Frontline Gastroenterol . 2023 Jul; 14(4):334-342. PMID: 37409334
Introduction: Liver transplantation (LT) remains integral to the management of end-stage chronic liver disease (CLD). However, referral thresholds and assessment pathways remain poorly defined. Distance from LT centre has been...
3.
Ahmed W, Kyle D, Khanna A, Devlin J, Reffitt D, Zeino Z, et al.
Therap Adv Gastroenterol . 2022 Oct; 15:17562848221122473. PMID: 36187366
Background: Fully covered intraductal self-expanding metal stents (IDSEMS) have been well described in the management of post-liver transplant (LT) anastomotic strictures (ASs). Their antimigration waists and intraductal nature make them...
4.
Pradeep A, Barker F, Ramos K, Littlejohn W, Tavabie O, Nicholson C, et al.
Frontline Gastroenterol . 2022 Jun; 13(4):360-362. PMID: 35722597
No abstract available.
5.
Williams R, Alessi C, Alexander G, Allison M, Aspinall R, Batterham R, et al.
Lancet . 2021 Mar; 397(10286):1770-1780. PMID: 33714360
This Review, in addressing the unacceptably high mortality of patients with liver disease admitted to acute hospitals, reinforces the need for integrated clinical services. The masterplan described is based on...
6.
McKeating C, Cadden I, McDougall N, Jessop L, Quah S, Lavelle M, et al.
Ulster Med J . 2018 Dec; 87(3):177-180. PMID: 30559541
Purpose: The rate of progression of acute Hepatitis B (HBV) to chronic disease is quoted as <10%. The purpose of this study was to determine the rate of progression from...
7.
Williams R, Alexander G, Aspinall R, Batterham R, Bhala N, Bosanquet N, et al.
Lancet . 2018 Nov; 392(10162):2398-2412. PMID: 30473364
This report presents further evidence on the escalating alcohol consumption in the UK and the burden of liver disease associated with this major risk factor, as well as the effects...
8.
Williams R, Alexander G, Armstrong I, Baker A, Bhala N, Camps-Walsh G, et al.
Lancet . 2017 Dec; 391(10125):1097-1107. PMID: 29198562
This report contains new and follow-up metric data relating to the eight main recommendations of the Lancet Standing Commission on Liver Disease in the UK, which aim to reduce the...
9.
Feeney S, McCaughey C, Watt A, Agnaf M, McDougall N, Wend U, et al.
J Med Virol . 2013 Jan; 85(4):597-601. PMID: 23359331
Screening hepatitis B virus (HBV) surface antigen (HBsAg) and HBV core antibody (anti-HBc) is recommended prior to cytotoxic or immunosuppressive therapy. This case describes an anti-HBc negative, DNA positive occult...
10.
Hunter M, Loughrey M, Gray M, Ellis P, McDougall N, Callender M
Ulster Med J . 2012 Feb; 80(1):15-8. PMID: 22347734
Aims: Overlap syndromes constitute a significant proportion of autoimmune liver disease. Our aim was to describe our cohort and evaluate practical methods of correctly diagnosing autoimmune hepatitis/primary sclerosing cholangitis overlap...